Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud (Q41728053)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 September 2014

Language	Label	Description	Also known as
English	Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective stud	scientific article published on 23 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Caroline Besson

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Josep-Maria Ribera

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Joseph M Connors

13

object named as

Joseph M Connors

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

19

object named as

Julie M Vose

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Jeremy S Abramson

10

object named as

Jeremy S Abramson

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

8

object named as

Silvia Montoto

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Jérémy Brühlmann

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Paula Y Tanaka

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Kate Cwynarski

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Samir Dalia

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Michael Furman

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Minh-Ly Nguyen

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Timothy P Cooley

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Jaime A Collins

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

HIV-Associated Hodgkin Lymphoma in the cART Era Study Group

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Hansjakob Furrer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

0 references

publication date

23 September 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

121

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

423-431

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Hodgkin lymphoma among patients infected with HIV in post-HAART era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Revised response criteria for malignant lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Inference and missing data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

21 January 2018

Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29066

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.29066

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251326%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41728053&oldid=1858064391"